Adis Journals
Browse
Summary Slide.png (107.16 kB)

Pharmacokinetics, Safety and Tolerability of Once-Weekly Subcutaneous Semaglutide in Healthy Chinese Subjects: A Double-Blind, Phase 1, Randomized Controlled Trial

Download (107.16 kB)
figure
posted on 2020-11-05, 10:30 authored by Aixin Shi, Panpan Xie, Lasse Lykke Nielsen, Trine Vang Skjøth, Xuemei He, Sine Pfeiffer Haugaard

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Usage metrics

    Advances in Therapy

    Categories

    Keywords

    DiabetesGlucagon-like peptide-1 receptor agonistPharmacokineticsRandomised controlled trialSemaglutideSteady state exposure

    Licence

    CC BY-NC 4.0

    Exports